1. Stocks
    2. /
  2. Immutep Limited (ASX: IMM)
    3. /

Immutep Limited (ASX: IMM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Immutep Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Immutep Limited (ASX: IMM)
    Latest News

    four people celebrate with champagne in front of gold 2022 balloons
    Best Shares

    Top ASX shares to buy in January 2022

    | Motley Fool Staff

    Made some new-year's investing resolutions? Here are some expert stock picks to consider inviting to the party.

    Read more »

    a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
    Healthcare Shares

    3 ASX biotech shares rated as buys in 2022

    | Zach Bristow

    We hear the expert opinion of analysts covering the space.

    Read more »

    Man in whit coat after explosion.
    Healthcare Shares

    2 ASX healthcare shares set to explode 70% in 2022: expert

    | Tony Yoo

    Biotech and health stocks can fluctuate wildly, but when things go right they can be very rewarding for investors. Here's…

    Read more »

    A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
    Healthcare Shares

    Here's why the Immutep (ASX:IMM) share price is up today

    | Monica O'Shea

    Immutep has signed a new agreement on a key antibody product.

    Read more »

    young female doctor with digital tablet looking confused.
    Healthcare Shares

    Immutep (ASX:IMM) share price slips amid trial safety update

    | Bernd Struben

    Initial study results look promising but investors don't appear too excited...

    Read more »

    share price dropping
    Share Market News

    Why Afterpay, Immutep, Pushpay, and Vulcan shares are falling

    | James Mickleboro

    These ASX shares are in the red today...

    Read more »

    A doctor in a white coat with a stethoscope around her neck holds her hands upwards as if to ask 'why' as she sits at her desk and looks at her computer.
    Healthcare Shares

    Immutep (ASX:IMM) share price slides 20% despite latest trial results

    | Zach Bristow

    The biotech company's shares are plunging despite positive news on its latest drug trial.

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Here's why the Immutep (ASX:IMM) share price is rising on Tuesday

    | Aaron Teboneras

    The company is expanding its intellectual property portfolio. We have the details

    Read more »

    man pointing up at a rising red line which represents a growing share price
    Healthcare Shares

    Immutep (ASX:IMM) share price hikes amid clinical trial momentum in FY21

    | Zach Bristow

    Here we unpack the biotech company's annual report to see where it made most progress in FY21.

    Read more »

    four excited doctors with their hands in the air
    Share Gainers

    The Immutep (ASX:IMM) share price is up 25% in a month and could go higher

    | James Mickleboro

    This biotech company's shares have been on fire...

    Read more »

    stock market gaining
    Share Gainers

    Why BlueBet, Dicker Data, Immutep, & Sandfire are charging higher

    | James Mickleboro

    These ASX shares are starting the month strongly...

    Read more »

    smiling health care workers in a medical setting
    Healthcare Shares

    Why the Immutep (ASX:IMM) share price is leaping 5% today

    | Brooke Cooper

    Immutep is one step closer to finishing its TACTI-002 trial.

    Read more »

    Frequently Asked Questions

    No, Immutep does not pay dividends at this time.

    Immutep Ltd listed on the ASX on 23 June 1988.

    IMM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Immutep Limited

    Immutep Ltd (ASX: IMM) is a biotechnology company developing immunotherapy products for cancer and autoimmune diseases. The company describes itself as a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Immutep's LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune diseases. Immutep currently has three clinical-stage candidates and two earlier-stage candidates.

    Profile

    since

    Note